Mark Miller

The legislation makes the most significant changes to Medicare in almost two decades.

Higher fees can significantly eat into returns when investors move out of their workplace plans.

The short-term outlook for these programs has improved, but challenges and uncertainties loom.

The answer depends on healthcare costs, Social Security benefits, and your own financial circumstances.

The answer depends on healthcare costs, Social Security benefits, and your own financial circumstances.

Accountable care organizations may replace the fee-for-service model. Here's why that's concerning.

Carefully choosing a supplemental insurance plan is key if you're enrolled in traditional Medicare.

Medicare is a significant public policy achievement, but it's time for some urgently needed reforms.

The unique challenges posed by inflation will be the top story in the year ahead.

How to effectively and efficiently re-evaluate your prescription drug or Medicare Advantage coverage.

Retirees looking for a decent return in this low-rate climate would be wise to consider it.

The outlook for inflation and Medicare premiums complicates predicting what the net COLA will be for 2022.

For some income groups, job loss and early retirement have been higher than in the Great Recession.

Congress could mitigate inequities with some sensible Medicare program reforms, says Morningstar contributor Mark Miller.

The current system dates to the 1950s--and much has changed since then.

Congress continues to change the RMD rules, but contributor Mark Miller argues the activity isn't improving retirement security.

Medicare and Social Security solvency are among the top retirement challenges this year, says contributor Mark Miller.

A shortage of age-friendly communities may make it challenging.

Meager cost-of-living adjustments coupled with Part B increases continue to erode the standard of living for many retirees.

How to effectively and efficiently re-evaluate your prescription drug or Medicare Advantage coverage.

The next administration will face several healthcare-related issues. Contributor Mark Miller unpacks some of them.

The next administration will face key policy questions related to the program's long-term solvency, says contributor Mark Miller.

Why retiring early in the face of COVID-19 may spell bad news for your plan.

Contributor Mark Miller discusses the pros and cons to consider before accepting these offers.

Contributor Mark Miller examines the health of these critical programs in the face of the COVID-19 crisis.

Contributor Mark Miller explores the health of corporate, multiemployer, and public plans.

Things have become more complicated, writes contributor Mark Miller.

Contributor Mark Miller walks through the various products and features and discusses for whom they’re best suited.